Gladstone Home spacer GICD
 
 
Supporting Gladstone
2006
Untitled Document

Ali T, Humphries J, Burnand K, Sawyer B, Bursill C, Channon K, Greaves D, Rollins B, Charo IF, Smith A (2006) Monocyte recruitment in venous thrombus resolution. J. Vasc. Surg. 43:601–608.

Aslanian AM, Charo IF (2006) Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation 114:583–590.

Bersot T, Haffner S, Harris WS, Kellick KA, Morris CM (2006) Hypertriglyceridemia: management of atherogenic dyslipidemia. J. Fam. Pract. 55:S1–S8.

Braun NA, Mohler PJ, Weisgraber KH, Hasty AH, Linton MF, Yancey PG, Su YR, Fazio S, Swift LL (2006) Intracellular trafficking of recycling apolipoprotein E in Chinese hamster ovary cells. J. Lipid Res. 47:1176–1186.

Capellini TD, Di Giacomo G, Salsi V, Brendolan A, Ferretti E, Srivastava D, Zappavigna V, Selleri L (2006) Pbx1/Pbx2 requirement for distal limb patterning is mediated by the hierarchical control of Hox gene spatial distribution and Shh expression. Development 133:2263–2273.

Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354:610–621.

Farese RV, Jr. (2006) The nine lives of ACAT inhibitors. Arterioscler. Thromb. Vasc. Biol. 26:1684–1686.

Feldman BJ, Streeper RS, Farese RV, Jr., Yamamoto KR (2006) Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc. Natl. Acad. Sci. USA 103:15675–15680.

Gong B, Trent MB, Srivastava D, Boor PJ (2006) Chemical-induced, nonlethal, developmental model of dissecting aortic aneurysm. Birth Defects Res. A Clin. Mol. Teratol. 76:29–38.

Green SR, Han KH, Chen Y, Almazan F, Charo IF, Miller YI, Quehenberger O (2006) The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK. J. Immunol. 176:7412–7420.

Hatters DM, Peters-Libeu CA, Weisgraber KH (2006) Apolipoprotein E structure: Insights into function. Trends Biochem. Sci. 31:445–454.

Hodoglugil U, Mahley RW (2006) Smoking and obesity make a bad problem worse: genetics and lifestyle affect high density lipoprotein levels in Turks. Anadolu Kardiyol. Derg. 6:60–67.

Hodoglugil U, Tanyolac S, Williamson DW, Huang Y, Mahley RW (2006) Apolipoprotein A-V: A potential modulator of plasma triglyceride levels in Turks. J. Lipid Res. 47:144–153.

Huang Y (2006) Transgenic and gene-targeted mouse models of hyperlipidemia. In: A Handbook of Mouse Models for Cardiovascular Research (Xu Q, ed) John Wiley & Sons, West Sussex, England, pp 33–41.

Ivey KN, Srivastava D (2006) The paradoxical patent ductus arteriosus. J. Clin. Invest. 116:2863–2865.

Ji Z-S, Müllendorff K, Cheng IH, Miranda RD, Huang Y, Mahley RW (2006) Reactivity of apolipoprotein E4 and amyloid b peptide: Lysosomal stability and neurodegeneration. J. Biol. Chem. 281:2683–2692.

King IN, Kathiriya IS, Murakami M, Nakagawa M, Gardner KA, Srivastava D, Nakagawa O (2006) Hrt and Hes negatively regulate Notch signaling through interactions with RBP-Jk. Biochem. Biophys. Res. Commun. 345:446–452.

Koshiba-Takeuchi K, Takeuchi JK, Arruda EP, Kathiriya IS, Mo R, Hui CC, Srivastava D, Bruneau BG (2006) Cooperative and antagonistic interactions between Sall4 and Tbx5 pattern the mouse limb and heart. Nat. Genet. 38:175–183.

Maeda J, Yamagishi H, McAnally J, Yamagishi C, Srivastava D (2006) Tbx1 is regulated by forkhead proteins in the secondary heart field. Dev. Dyn. 235:701–710.

Mahley RW, Bersot TP (2006) Drug therapy for hypercholesterolemia and dyslipidemia. In: Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 11th edition (Brunton LL, Lazo JS, Parker KL, eds) McGraw-Hill, New York. pp. 933–966.

Mahley RW, Bersot TP (2006) High density lipoprotein cholesterol in coronary artery patients: is it as low as expected? Anadolu Kardiyol. Derg. 6:94–96; author reply 96.

Mahley RW, Huang Y, Weisgraber KH (2006) Putting cholesterol in its place: apoE and reverse cholesterol transport. J. Clin. Invest. 116:1226–1229.

Mahley RW, Huang Y (2007) Atherogenic remnant lipoproteins: Role for proteoglycans in trapping, transferring, internalizing. J. Clin. Invest. 117:94–98.

Millar JS, Stone SJ, Tietge UJ, Tow B, Billheimer JT, Wong JS, Hamilton RL, Farese RV, Jr., Rader DJ (2006) Short-term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production. J. Lipid Res. 47:2297–2305.

Mori AD, Zhu Y, Vahora I, Nieman B, Koshiba-Takeuchi K, Davidson L, Pizard A, Seidman JG, Seidman CE, Chen XJ, Henkelman RM, Bruneau BG (2006) Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis. Dev. Biol. 297:566–586.

Nicholls RE, Zhang XL, Bailey CP, Conklin BR, Kandel ER, Stanton PK. (2006) mGluR2 acts through inhibitory Galpha subunits to regulate transmission and long-term plasticity at hippocampal mossy fiber-CA3 synapses. Proc. Natl. Acad. Sci. USA 103:6380–6385.

Nord AS, Chang PJ, Conklin BR, Cox AV, Harper CA, Hicks GG, Huang CC, Johns SJ, Kawamoto M, Liu S, Meng EC, Morris JH, Rossant J, Ruiz P, Skarnes WC, Soriano P, Stanford WL, Stryke D, von Melchner H, Wurst W, Yamamura K, Young SG, Babbitt PC, Ferrin TE (2006) The International Gene Trap Consortium Website: A portal to all publicly available gene trap cell lines in mouse. Nucleic Acids Res. 34:D642–D6428.

Oshima T, Sonoda KH, Tsutsumi-Miyahara C, Qiao H, Hisatomi T, Nakao S, Hamano S, Egashira K, Charo IF, Ishibashi T (2006) Analysis of corneal inflammation induced by cauterisation in CCR2 and MCP-1 knockout mice. Br. J. Ophthalmol. 90:218–222.

Peters-Libeu CA, Newhouse Y, Hatters DM, Weisgraber KH (2006) Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine. J. Biol. Chem. 281:1073–1079.

Ragozzino D, Di Angelantonio S, Trettel F, Bertollini C, Maggi L, Gross C, Charo IF, Limatola C, Eusebi F (2006) Chemokine fractalkine/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons. J. Neurosci. 26:10488–10498.

Ramana KV, Willis MS, White MD, Horton JW, DiMaio JM, Srivastava D, Bhatnagar A, Srivastava SK (2006) Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition. Circulation 114:1838–1846.

Rizki G, Arnaboldi L, Gabrielli B, Yan J, Lee GS, Ng RK, Turner SM, Badger TM, Pitas RE, Maher JJ (2006) Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1. J. Lipid Res. 47:2280–2290.

Rudel LL, Farese RV, Jr. (2006) ACAT inhibition and the progression of coronary atherosclerosis. N. Engl. J. Med. 354:2616–2617; author reply 2616–2617.

Safar JG, Wille H, Geschwind MD, Deering C, Latawiec D, Serban A, King DJ, Legname G, Weisgraber KH, Mahley RW, Miller BL, Dearmond SJ, Prusiner SB (2006) Human prions and plasma lipoproteins. Proc. Natl. Acad. Sci. USA 103:11312–11317.

Sautter NB, Shick EH, Ransohoff RM, Charo IF, Hirose K (2006) CC chemokine receptor 2 is protective against noise-induced hair cell death: Studies in CX3CR1(+/GFP) mice. J. Assoc. Res. Otolaryngol. 7:361–372.

Srivastava D. (2006) Making or breaking the heart: From lineage determination to morphogenesis. Cell 126:1037–1048.

Srivastava D, Ivey KN. (2006) Potential of stem-cell-based therapies for heart disease. Nature 441:1097–1099.

Srivastava D, Yu S. (2006) Stretching to meet needs: Integrin-linked kinase and the cardiac pump. Genes Dev. 20:2327–2331.

Srivastava D (2006) Genetic regulation of cardiogenesis and congenital heart disease. Ann. Rev. Pathol. Mech. Dis. 1:199–213.

Stone SJ, Levin M, Farese RV, Jr. (2006) Murine acyl CoA:diacylglycerol acyltransferase-2 (DGAT2): Membrane topology and identification of key functional amino acid residues. J. Biol. Chem. 281:40273–40282.

Streeper RS, Koliwad SK, Villanueva CJ, Farese RV, Jr. (2006) Effects of DGAT1 deficiency on energy and glucose metabolism are independent of adiponectin. Am. J. Physiol. Endocrinol. Metab. 291:E388–E394.

Takeuchi JK, Bruneau BG (2006) Irxl1, a divergent Iroquois homeobox family transcription factor gene. Gene Expr. Patterns 7:51–56.

Turnbull L, Zhou HZ, Swigart PM, Turcato S, Karliner JS, Conklin BR, Simpson PC, Baker AJ (2006) Sustained preconditioning induced by cardiac transgenesis with the tetracycline transactivator. Am. J. Physiol. Heart Circ. Physiol. 290:H1103–H1109.

Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW, Jr. (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116:115–124.

Yamagishi C, Yamagishi H, Maeda J, Tsuchihashi T, Ivey K, Hu T, Srivastava D. (2006) Sonic hedgehog is essential for first pharyngeal arch development. Pediatr. Res. 59:349–354.

Yen CL, Farese RV, Jr. (2006) Fat breakdown: A function for CGI-58 (ABHD5) provides a new piece of the puzzle. Cell Metab. 3:305–307.


Gladstone Home | Cardiovascular Disease | Virology and Immunology | Neurological Disease | Administration | UCSF